Meeting
2023 ASCO Genitourinary Cancers Symposium
Geographic variation of decipher genomic classifier in patients with early prostate cancer.
Authors
Daniel Keizman
Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
Daniel Keizman , Elai Davicioni , Avivit Peer , Hadas Dresler , Avishay Sella , David Leonid Sarid , Keren Rouvinov , Yoav Manaster
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 376)
DOI
10.1200/JCO.2023.41.6_suppl.376
Abstract #
376
Poster Bd #
N14
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
The impact of genomic biomarkers on a validated clinical risk prediction model for upgrading/upstaging among men with low-risk prostate cancer.
First Author: Avery Braun
Poster
2022 ASCO Genitourinary Cancers Symposium
Validation of the performance of the Decipher biopsy genomic classifier in intermediate-risk prostate cancer on the phase III randomized trial NRG Oncology/RTOG 0126.
First Author: Daniel Eidelberg Spratt
Poster
2021 Genitourinary Cancers Symposium
Treatment decisions and outcomes for NCCN favorable intermediate-risk prostate cancer patients after receiving the 17-gene genomic prostate cancer score result.
First Author: Eric Margolis
Poster
2021 Genitourinary Cancers Symposium
Genomic analysis for active surveillance to predict upstaging after prostatectomy.
First Author: Andrea Quinn